Key Considerations for Dosage Regimen Patents at the EPO 

Tuesday, Sept. 9, 2025

Time: 10 AM Pacific / 12 PM Central / 1 PM Eastern

Place: Virtual - Zoom

Cost: Complimentary

CLE Credit: We will apply for 1.0 hours of CLE credit for Minnesota, California, Texas and Washington state

Join us for the first episode of the SLW Chemistry and Biology Webinar Series. In this inaugural episode, guest speakers Charlotte Watkins and Hazel Robson of Secerna LLP will present on dosage regimens from a small molecule and alternatively a biological molecule perspective and identify potential divergent approaches from the EPO.

Charlotte Watkins is a Chartered Patent Attorney in the UK, a European Patent Attorney and a UPC Representative. A founding partner at Secerna, she has practiced in the field of Intellectual Property since 2001, working primarily in the life sciences sector. She also has wide experience in patent enforcement and defense globally. As well as being highly experienced before the UK Intellectual Property Office and European Patent Office, Charlotte has a notable knowledge of the patent systems of many other key jurisdictions.

Hazel Robson is a senior associate at Secerna. A Chartered Patent Attorney in the UK and a European Patent Attorney, Hazel Robson is an accomplished intellectual property attorney with a deep understanding of the pharmaceutical and chemical landscapes. Her expertise spans a broad range of pharmaceutical IP, encompassing new chemical entities, polymorphs, formulations, manufacturing processes, and medical devices. With a strong foundation gained from supporting drug discovery, development, and clinical trials at a global pharmaceutical company, Hazel brings a wealth of industry knowledge and strategic acumen to her work.

If you enjoyed the SLW Life Sciences Webinar Series, join us for the new SLW Chemistry and Biology Webinar Series. Nicholas Lanzatella is back to moderate the event. Fill out the form to register today.